Guardian Australia · GSK
GSK reports promising early results in ovarian and womb cancer drug trial
· By Juliakollewe
Story summaryMo-Rez reduced or eliminated tumours in over 60% of patients and is expected to be a blockbuster drug
Read at Guardian Australia ↗
Opens the original publisher in a new tab. Full articles belong to their publishers; a subscription may be required.